Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease

Li Zhengyu; Gan Li; Yan Si; Yan Yufang; Huang Wei

doi:10.1515/tnsci-2020-0101

Translational Neuroscience (May 2020)

Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease

Li Zhengyu,
Gan Li,
Yan Si,
Yan Yufang,
Huang Wei

Affiliations

Li Zhengyu: Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Gan Li: Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Yan Si: Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Yan Yufang: Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Huang Wei: Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China

DOI: https://doi.org/10.1515/tnsci-2020-0101
Journal volume & issue: Vol. 11, no. 1
pp. 161 – 172

Abstract

Read online

Amyloid-beta (Aβ) plaque deposits and neurofibrillary tangles containing tau proteins are the key pathognomonic manifestations of Alzheimer’s disease (AD). Lack of holistic drugs for AD has reinvigorated enthusiasm in the natural product-based therapies. In this study, our idea to decipher the beneficial effects of C-phycocyanin (CPC) in the management of AD is buoyed by its multifaceted and holistic therapeutic effects.

Published in Translational Neuroscience

ISSN: 2081-6936 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.degruyter.com/view/j/tnsci

About the journal

Abstract

Keywords